LEADER 01292nam  2200445   450 
001 9910502586503321
005 20220706094013.0
010   $a3-030-78338-3
035   $a(CKB)5100000000044224
035   $a(MiAaPQ)EBC6767924
035   $a(Au-PeEL)EBL6767924
035   $a(OCoLC)1276860688
035   $a(PPN)258298251
035   $a(EXLCZ)995100000000044224
100   $a20220706d2021      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aNanoparticle-mediated immunotherapy /$fTuan Vo-Dinh, editor
210  1$aCham, Switzerland :$cSpringer,$d[2021]
210  4$dİ2021
215   $a1 online resource (269 pages)
225 1 $aBioanalysis ;$vVolume 12
311   $a3-030-78337-5 
410  0$aBioanalysis (Springer (Firm)) ;$vVolume 12.
606   $aImmunotherapy$xTechnological innovations
606   $aNanoparticles
615  0$aImmunotherapy$xTechnological innovations.
615  0$aNanoparticles.
676   $a616.079
702   $aVo-Dinh$b Tuan
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910502586503321
996   $aNanoparticle-mediated immunotherapy$92898413
997   $aUNINA